Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Allotment

 The Operation committee of Directors of the Company at its meeting held on November 27, 2019 at 6 PM has approved the following; 1) Allotment of 11,00,000 (Eleven Lakh) equity Shares of Rs. 10/- (Rupees Ten) each for cash at a price of Rs. 26 /- (Rupees Twenty Six only) per share (including a premium of Rs. 16/- per share), the price has been calculated in accordance with the SEBI (ICDR) Regulations, 2018, aggregating to Rs. 2,86,00,000 /- (Rupees 2 Crores 86 Lakhs) on preferential basis to Strategic Investors not forming part of Promoters Group of the Company.
27-11-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation Of Appointment Of Chief Executive Officer (CEO)

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today has considered and approved the appointment of Mr. Ravindra R. Desai, as Chief Executive Officer of the Company.
06-11-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2019

 This is to inform you that the Board of Directors of the Company, at their meeting held today at 3 p.m. has Approved the un-audited financial results of the Company for the quarter and half year ended September 30, 2019. The above financial Results along with the Limited Review Report on the Financial Results are enclosed herewith. The meeting of the Board of Directors was concluded at 5.00 p.m.
02-11-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2019

 This is to inform you that the Board of Directors of the Company, at their meeting held today at 3 p.m. has Approved the un-audited financial results of the Company for the quarter and half year ended September 30, 2019. The above financial Results along with the Limited Review Report on the Financial Results are enclosed herewith. The meeting of the Board of Directors was concluded at 5.00 p.m.
02-11-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Outcome of Board Meeting

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today has approved the unaudited Financial Results for the second quarter and half year ended September 30, 2019.
02-11-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Intimation Of Date Of Board Meeting For Consideration Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2019

 Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2019 ,inter alia, to consider and approve We wish to inform you that, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 02, 2019 to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2019. We request you to take the same on your records.
26-10-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we are forwarding herewith a copy of the certificate dated October 09, 2019, received from M/S. Sharex Dynamic (India) Pvt. Ltd. the Registrar and Transfer Agent of the Company, for the quarter ended September 30, 2019. We request you to kindly take above on the records. Thanking You.
24-10-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2019

 We send herewith a certificate for half-year ended September 30, 2019, duly signed by Mr. S.K. Pandey, Practicing Company Secretaries, pursuant to the provisions under Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking You
23-10-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliance Certificate For Half Year Ended September 30, 2019

 We are enclosing herewith Compliance certificate under Regulation 7(3) of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015 for the half year ended September 30, 2019.
22-10-2019
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended September 30, 2019

 Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
19-10-2019
Next Page
Close

Let's Open Free Demat Account